{"entity":{"type":"insider","cik":"0001800670","url":"/insider/0001800670","json_url":"/insider/0001800670.json","name":"Weber Barbara","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":10,"first":"2020-08-14","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Weber Barbara","source":"filing","n_filings":10,"first_seen":"2020-08-14","last_seen":"2026-02-04"}],"transactions":[{"id":6058094,"accession":"0001193125-26-038070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-038070","line_url":"/filing/0001193125-26-038070#line-3","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Director, Executive Chair)","officer_title":"Director, Executive Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30186.0,"shares_display":"30,186","price_per_share":12.2573,"price_display":"12.26","price_state":"stated","total_value":369998.8578,"total_display":"369,998.86","shares_owned_after":1629587.0,"shares_owned_after_display":"1,629,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":6058091,"accession":"0001193125-26-038070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-038070","line_url":"/filing/0001193125-26-038070#line-2","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Director, Executive Chair)","officer_title":"Director, Executive Chair","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":12.8971,"price_display":"12.90","price_state":"stated","total_value":4294.7343,"total_display":"4,294.73","shares_owned_after":1629254.0,"shares_owned_after_display":"1,629,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":4311517,"accession":"0000950170-25-015684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-015684","line_url":"/filing/0000950170-25-015684#line-2","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9013.0,"shares_display":"9,013","price_per_share":3.1614,"price_display":"3.16","price_state":"stated","total_value":28493.6982,"total_display":"28,493.70","shares_owned_after":1622251.0,"shares_owned_after_display":"1,622,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-06","scope":"insider"},{"id":4311512,"accession":"0000950170-25-015684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-015684","line_url":"/filing/0000950170-25-015684#line-1","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9778.0,"shares_display":"9,778","price_per_share":2.988,"price_display":"2.99","price_state":"stated","total_value":29216.664,"total_display":"29,216.66","shares_owned_after":1631264.0,"shares_owned_after_display":"1,631,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":2869989,"accession":"0001610717-24-000504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000504","line_url":"/filing/0001610717-24-000504#line-1","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5200.0,"shares_display":"5,200","price_per_share":48.0224,"price_display":"48.02","price_state":"stated","total_value":249716.48,"total_display":"249,716.48","shares_owned_after":13065.0,"shares_owned_after_display":"13,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-08","filed_date":"2024-10-10","scope":"insider"},{"id":3018644,"accession":"0000950170-24-012999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-012999","line_url":"/filing/0000950170-24-012999#line-2","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4457.0,"shares_display":"4,457","price_per_share":12.6198,"price_display":"12.62","price_state":"stated","total_value":56246.4486,"total_display":"56,246.45","shares_owned_after":1535167.0,"shares_owned_after_display":"1,535,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":3018639,"accession":"0000950170-24-012999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-012999","line_url":"/filing/0000950170-24-012999#line-1","is_derivative":false,"issuer_cik":"0001800670","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001800670","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4681.0,"shares_display":"4,681","price_per_share":12.5626,"price_display":"12.56","price_state":"stated","total_value":58805.5306,"total_display":"58,805.53","shares_owned_after":1539624.0,"shares_owned_after_display":"1,539,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":7982606,"accession":"0001610717-23-000260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001610717-23-000260","line_url":"/filing/0001610717-23-000260#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":35.0667,"price_display":"35.07","price_state":"stated","total_value":526000.5,"total_display":"526,000.50","shares_owned_after":15825.0,"shares_owned_after_display":"15,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-06","scope":"insider"},{"id":5496622,"accession":"0001567619-21-002350","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-002350","line_url":"/filing/0001567619-21-002350#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":50.0234,"price_display":"50.02","price_state":"stated","total_value":205095.94,"total_display":"205,095.94","shares_owned_after":2708.0,"shares_owned_after_display":"2,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":5496619,"accession":"0001567619-21-002350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-002350","line_url":"/filing/0001567619-21-002350#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":51.8567,"price_display":"51.86","price_state":"stated","total_value":46671.03,"total_display":"46,671.03","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":4995456,"accession":"0001567619-21-002062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-002062","line_url":"/filing/0001567619-21-002062#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5336.0,"shares_display":"5,336","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":240120.0,"total_display":"240,120.00","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":4941970,"accession":"0001567619-21-000102","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-000102","line_url":"/filing/0001567619-21-000102#line-3","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5236.0,"shares_display":"5,236","price_per_share":40.9467,"price_display":"40.95","price_state":"stated","total_value":214396.9212,"total_display":"214,396.92","shares_owned_after":1908.0,"shares_owned_after_display":"1,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider"},{"id":4941964,"accession":"0001567619-21-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-000102","line_url":"/filing/0001567619-21-000102#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":41.33,"price_display":"41.33","price_state":"stated","total_value":4133.0,"total_display":"4,133.00","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider"},{"id":3227835,"accession":"0001567619-20-017604","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-017604","line_url":"/filing/0001567619-20-017604#line-6","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7196.0,"shares_display":"7,196","price_per_share":36.1747,"price_display":"36.17","price_state":"stated","total_value":260313.1412,"total_display":"260,313.14","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-05","scope":"insider"},{"id":3227825,"accession":"0001567619-20-017604","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-20-017604","line_url":"/filing/0001567619-20-017604#line-4","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":804.0,"shares_display":"804","price_per_share":36.0193,"price_display":"36.02","price_state":"stated","total_value":28959.5172,"total_display":"28,959.52","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-02","filed_date":"2020-10-05","scope":"insider"},{"id":3227812,"accession":"0001567619-20-017604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-017604","line_url":"/filing/0001567619-20-017604#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":34.7605,"price_display":"34.76","price_state":"stated","total_value":69521.0,"total_display":"69,521.00","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider"},{"id":2203645,"accession":"0001567619-20-015578","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-20-015578","line_url":"/filing/0001567619-20-015578#line-4","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":9324.0,"total_display":"9,324.00","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-14","scope":"insider"},{"id":2203637,"accession":"0001567619-20-015578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-015578","line_url":"/filing/0001567619-20-015578#line-2","is_derivative":false,"issuer_cik":"0001628171","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001628171","owner_cik":"0001800670","owner_name":"Weber Barbara","owner_url":"/insider/0001800670","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1667.0,"shares_display":"1,667","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":46676.0,"total_display":"46,676.00","shares_owned_after":1808.0,"shares_owned_after_display":"1,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Director, Officer (Director, Executive Chair)","n_filings":3,"first_seen":"2024-02-08","last_seen":"2026-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Director","n_filings":7,"first_seen":"2020-08-14","last_seen":"2024-10-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001800670","retrieved_at":"2026-08-21T20:18:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}